Combination Therapy: The Propitious Rationale for Drug Development

Publisher： Bentham Science Publishers

E-ISSN： 1875-5402|17|1|53-67

ISSN： 1386-2073

Source： Combinatorial Chemistry & High Throughput Screening, Vol.17, Iss.1, 2014-01, pp. : 53-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Selective Release System Based on Dual‐Drug‐Loaded Mesoporous Silica for Nanoparticle‐Assisted Combination Therapy

By  

CHEMISTRY - A EUROPEAN JOURNAL, Vol. 20, Iss. 25, 2014-06 ,pp. : 7796-7802

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of Drug Transporter Interactions in Drug Discovery and Development

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 13, Iss. 2, 2010-02 ,pp. : 112-134

Bentham Science Publishers

Access to resources Recommend Favorite

Homochiral Drug Design and Development by Racemization

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 10, Iss. 5, 2007-06 ,pp. : 326-335

Bentham Science Publishers

Access to resources Recommend Favorite

Virtual Screening in Drug Design and Development

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 13, Iss. 5, 2010-06 ,pp. : 442-453

Bentham Science Publishers

Access to resources Recommend Favorite

A Sweet Polydopamine Nanoplatform for Synergistic Combination of Targeted Chemo‐Photothermal Therapy

By  

MACROMOLECULAR RAPID COMMUNICATIONS, Vol. 36, Iss. 10, 2015-05 ,pp. : 916-922

John Wiley & Sons Inc

Access to resources Recommend Favorite